Business
Admission to AIM and First Day of Dealings
Admission to AIM and First Day of Dealings.
About this update from Emv Capital Plc
[{"type":"text","content":"\n \nRNS Number : 0184O NetScientific PLC 16 September 2013 \n \n\nNOT FOR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN, AUSTRALIA OR THE REPUBLIC OF IRELAND OR IN, INTO OR FROM ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION\n \n\n\n\n\nFor Immediate Release\n\n\n16 September 2013\n\n\n\n\n \nNetScientific plc \n(\"NetScientific\" or the \"Group\")\n \nAdmission to AIM and First Day of Dealings\n \nNetScientific, the healthcare medical technology company, is pleased to announce that Admission and trading of its ordinary shares commences today on the AIM market of the London Stock Exchange (\"Admission\") under ticker symbol \"NSCI\".\n \n \nHighlights\n \n· The Group successfully raised £30 million via the placing of new ordinary shares at a price of 160 pence per share (the \"Placing\").\n \n· The net proceeds of the Placing will be used to fund working capital to accelerate to the market its two leading portfolio companies, WANDA, Inc. and Vortex BioSciences, Inc., whilst developing its other core spin-out companies and pipeline projects.\n \n· On Admission, the market capitalisation of the Group at the placing price will be £57.5 million. \n \n· The Company has an experienced Board with strong industry and business expertise, led by Sir Richard Sykes as Chairman.\n \nLiberum Capital is the Group's Nominated Adviser and Broker.\n \nFarad Azima, Chief Executive, NetScientific plc commented:\n \n\"The successful Admission to AIM represents an important milestone for the Group and we believe that, following our entry onto the market, we can build substantially on our current position.\n \nWe are passionate about investing in transformative technologies and believe we have the best people and network to identify, invest and bring to market innovations that will provide good returns for our shareholders and significant benefits to the healthcare industry.\"\n \n \nFor further information, please contact:\n \n\n\n\n\nLiberum Capital (Nomad & Broker)\nChris Bowman / Christopher Britton / Thom...